Edison Investment Research publishes first research on Cereno Scientific
Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced equity research company Edison Investment Research has published its first, in-depth research on the company.The research on Cereno Scientific is available on Edison’s website. Read the full research here . For further information, please contact: Henrik Westdahl,